Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
akcea therapeutics
anylam pharmaceuticals
avapritinib
biotech
blueprint medicines
boston
cancer
cancer drugs
capmatinib
cardiomyopathy
clinical trials
drugs
eli lilly
europe blog main
europe top stories
gastrointestinal stromal tumors
genentech
indiana blog main
indiana top stories
inotersen
life science
medullary thyroid cancer
neuropathy
new york
new york blog main
new york top stories
non-small cell lung cancer
novartis
onpattro
patisiran
pfizer
pralsetinib
roche
san diego blog main
san diego top stories
What
drug
fda
2
×
genetic
2
×
medicines
2
×
address
ago
akcea
alnylam
amyloidosis
approval
approved
approves
attr
available
battle
blueprint
cancer
carries
certain
debilitating
designed
disease
latest
oks
pass
patients
pfizer
rare
ret
sets
signature
signatures
targeted
targeting
therapy
transthyretin
year
Language
unset
Current search:
medicines
×
fda
×
genetic
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea